SPOTLIGHT -
Off-Label Comments Online: Keep Doing What You're Doing, Says FDA
Those in favor of a less is more approach to FDA social media guidelines got what they wanted for the holidays: a trim, 15-page document on how to respond to unsolicited off-label comments
Top Medical Innovations 2012
A selection of the recent breakthrough technologies showcased at the Cleveland Clinic's Medical Innovations Summit.
Artists & Ad Men
Some of the most creative and influential graphic designers and illustrators did time in pharma marketing.
The Rx Club's 25th Anniversary Show
Over 25 years the Rx Club Show has reflected dramatic technological changes in advertising. But, as always, the subject comes first, the medium second. So where did the accolades go this year?
Josef von Rickenbach: The Enterprising CRO
Josef von Rickenbach, President & CEO, Parexel
Three Decades of Politics and Pop Culture ... on Drugs
How to Prevent a Facebook Faux Pas
'Like' and 'Dislike' practices in the virtual Facebook pharmaceutical world.
Precious Mettle
Taking Onyx Pharmaceuticals to new heights – CEO Tony Coles talks to PharmExec about the midsize company's transition from adolescence to adulthood.
To Screen or Not to Screen?
What do our genetics tell us about our predisposition to certain diseases?